To assess the prognostic value of the C‐reactive protein‐albumin ratio (CAR) and the Glasgow Prognostic Score (GPS) in predicting overall survival (OS) rates among patients diagnosed with AML. The gene discussed is ALB; the disease is acute myeloid leukemia.